Literature DB >> 16416257

Duloxetine treatment for women awaiting continence surgery.

J R A Duckett1, I Aggarwal, A Patil.   

Abstract

The study assessed the effect of offering a 4-week course of duloxetine therapy to 73 women awaiting a tension-free vaginal tape (TVT) operation. Twenty-seven women (37%) declined taking the drug, leaving 46 women (63%) willing to take drug therapy. Thirteen women were scheduled for a TVT with concurrent prolapse surgery, and 1 of these women decided that she no longer needed the surgery. Eight of the 33(24%) women scheduled for a TVT without concurrent prolapse surgery came off the waiting list. Nine women of the 33 women scheduled for a TVT without concurrent surgery (27%) found that the medication did not work sufficiently well. Sixteen of the 33 women (48%) discontinued medication due to side-effects. Women on a waiting list for surgery may be unwilling to take duloxetine therapy and less tolerant of side-effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16416257     DOI: 10.1007/s00192-005-0063-9

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  11 in total

Review 1.  Reader's guide to critical appraisal of cohort studies: 1. Role and design.

Authors:  Paula A Rochon; Jerry H Gurwitz; Kathy Sykora; Muhammad Mamdani; David L Streiner; Susan Garfinkel; Sharon-Lise T Normand; Geoffrey M Anderson
Journal:  BMJ       Date:  2005-04-16

2.  Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.

Authors:  F P Bymaster; L J Dreshfield-Ahmad; P G Threlkeld; J L Shaw; L Thompson; D L Nelson; S K Hemrick-Luecke; D T Wong
Journal:  Neuropsychopharmacology       Date:  2001-12       Impact factor: 7.853

3.  Definition of overactive bladder and epidemiology of urinary incontinence.

Authors:  C Hampel; D Wienhold; N Benken; C Eggersmann; J W Thüroff
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

4.  Pharmacological treatment of women awaiting surgery for stress urinary incontinence.

Authors:  Linda Cardozo; Harold P Drutz; Simin K Baygani; Richard C Bump
Journal:  Obstet Gynecol       Date:  2004-09       Impact factor: 7.661

5.  Validation of two global impression questionnaires for incontinence.

Authors:  Ilker Yalcin; Richard C Bump
Journal:  Am J Obstet Gynecol       Date:  2003-07       Impact factor: 8.661

6.  Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response.

Authors:  Richard C Bump; Peggy A Norton; Norman R Zinner; Ilker Yalcin
Journal:  Obstet Gynecol       Date:  2003-07       Impact factor: 7.661

7.  Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.

Authors:  Roger R Dmochowski; John R Miklos; Peggy A Norton; Norman R Zinner; Ilker Yalcin; Richard C Bump
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

8.  Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.

Authors:  R J Millard; K Moore; R Rencken; I Yalcin; R C Bump
Journal:  BJU Int       Date:  2004-02       Impact factor: 5.588

9.  Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence.

Authors:  Karen Ward; Paul Hilton
Journal:  BMJ       Date:  2002-07-13

10.  Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.

Authors:  Philip van Kerrebroeck; Paul Abrams; Rainer Lange; Mark Slack; Jean-Jacques Wyndaele; Ilker Yalcin; Richard C Bump
Journal:  BJOG       Date:  2004-03       Impact factor: 6.531

View more
  1 in total

1.  Duloxetine as a treatment for stress incontinence--where are we now?

Authors:  Jonathan Duckett
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-09-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.